S&P 500   4,356.59 (+0.61%)
DOW   34,151.54 (+0.24%)
QQQ   361.26 (+0.95%)
AAPL   176.40 (+1.42%)
MSFT   320.39 (+0.27%)
META   303.33 (+2.57%)
GOOGL   131.67 (+0.94%)
AMZN   131.70 (+1.83%)
TSLA   254.95 (-0.29%)
NVDA   419.81 (+2.35%)
NIO   8.58 (+1.54%)
BABA   88.07 (+4.71%)
AMD   98.04 (+2.01%)
T   15.08 (-1.50%)
F   12.56 (+2.95%)
MU   69.19 (+1.90%)
CGC   0.83 (+8.56%)
GE   112.98 (+-0.01%)
DIS   82.28 (-0.54%)
AMC   7.99 (+3.77%)
PFE   32.79 (-0.18%)
PYPL   58.75 (+0.22%)
NFLX   383.94 (-0.05%)
S&P 500   4,356.59 (+0.61%)
DOW   34,151.54 (+0.24%)
QQQ   361.26 (+0.95%)
AAPL   176.40 (+1.42%)
MSFT   320.39 (+0.27%)
META   303.33 (+2.57%)
GOOGL   131.67 (+0.94%)
AMZN   131.70 (+1.83%)
TSLA   254.95 (-0.29%)
NVDA   419.81 (+2.35%)
NIO   8.58 (+1.54%)
BABA   88.07 (+4.71%)
AMD   98.04 (+2.01%)
T   15.08 (-1.50%)
F   12.56 (+2.95%)
MU   69.19 (+1.90%)
CGC   0.83 (+8.56%)
GE   112.98 (+-0.01%)
DIS   82.28 (-0.54%)
AMC   7.99 (+3.77%)
PFE   32.79 (-0.18%)
PYPL   58.75 (+0.22%)
NFLX   383.94 (-0.05%)
S&P 500   4,356.59 (+0.61%)
DOW   34,151.54 (+0.24%)
QQQ   361.26 (+0.95%)
AAPL   176.40 (+1.42%)
MSFT   320.39 (+0.27%)
META   303.33 (+2.57%)
GOOGL   131.67 (+0.94%)
AMZN   131.70 (+1.83%)
TSLA   254.95 (-0.29%)
NVDA   419.81 (+2.35%)
NIO   8.58 (+1.54%)
BABA   88.07 (+4.71%)
AMD   98.04 (+2.01%)
T   15.08 (-1.50%)
F   12.56 (+2.95%)
MU   69.19 (+1.90%)
CGC   0.83 (+8.56%)
GE   112.98 (+-0.01%)
DIS   82.28 (-0.54%)
AMC   7.99 (+3.77%)
PFE   32.79 (-0.18%)
PYPL   58.75 (+0.22%)
NFLX   383.94 (-0.05%)
S&P 500   4,356.59 (+0.61%)
DOW   34,151.54 (+0.24%)
QQQ   361.26 (+0.95%)
AAPL   176.40 (+1.42%)
MSFT   320.39 (+0.27%)
META   303.33 (+2.57%)
GOOGL   131.67 (+0.94%)
AMZN   131.70 (+1.83%)
TSLA   254.95 (-0.29%)
NVDA   419.81 (+2.35%)
NIO   8.58 (+1.54%)
BABA   88.07 (+4.71%)
AMD   98.04 (+2.01%)
T   15.08 (-1.50%)
F   12.56 (+2.95%)
MU   69.19 (+1.90%)
CGC   0.83 (+8.56%)
GE   112.98 (+-0.01%)
DIS   82.28 (-0.54%)
AMC   7.99 (+3.77%)
PFE   32.79 (-0.18%)
PYPL   58.75 (+0.22%)
NFLX   383.94 (-0.05%)
OTCMKTS:TRSBF

3SBio (TRSBF) Stock Forecast, Price & News

$0.80
0.00 (0.00%)
(As of 05/12/2023)
Compare
Today's Range
$0.80
$0.80
50-Day Range
$0.80
$0.80
52-Week Range
$0.80
$0.80
Volume
N/A
Average Volume
63,275 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About 3SBio

3SBio Inc., an investment holding company, develops, produces markets, and sells biopharmaceutical products in Mainland China and internationally. The company provides TPIAO, a recombinant human thrombopoietin to treat chemotherapy-induced thrombopenia and immune thrombocytopenia; Cipterbin, an anti-HER2 monoclonal antibody for the treatment of HER2-positive metastatic breast cancer in combination with chemotherapy; Interferon, a human interferon a2a for injection; and Inleusin, for the treatment of renal cell carcinoma, melanoma, thoracic fluid build-up caused by cancer and tuberculosis. It also offers YISAIPU, the receptor-antibody fusion tumor necrosis factor inhibitor; Mendi-minoxidil tincture, an OTC external medicine for treating hair loss; EPIAO and SEPO, an erythropoietin injection; SPARIN, an injectable low-molecular-weight heparin calcium; and Xenopax, a recombinant humanized anti-cd25 monoclonal antibody injection for prevention of acute rejection after renal transplantation. In addition, the company provides TPO-105 Pediatric ITP; SSS12 Cinacalcet hydrochloride; SSS13 Sevelamer carbonate; 301S TNFR-Fc protein; AP506 Apremilast; SSS32 Tofacitinib; and MN709 Minoxidil Foam. Further, the company provides trading, project management and consultation, technology, sports, financial, investment advisory, and agricultural services. It has collaboration agreements with companies, such as Toray Industries Inc, and Toray. The company was founded in 1993 and is headquartered in Shenyang, the People's Republic of China.

TRSBF Price History

TRSBF Stock News Headlines

See More Headlines
Receive TRSBF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 3SBio and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:TRSBF
CIK
N/A
Fax
N/A
Employees
5,311
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Dr. Jing Lou M.D. (Age 60)
    Ph.D., Co-Founder, Exec. Chairman, CEO & Pres
    Comp: $614.13k
  • Dr. Dongmei Su (Age 53)
    Sr. VP & Exec. Director
    Comp: $193.28k
  • Mr. Xiang He
    Chief Financial Officer
  • Ms. Siu Kuen Lai FCIS (Age 47)
    FCS, Company Sec.
  • Zhao Xinyi
    Exec. of IR













TRSBF Stock - Frequently Asked Questions

How have TRSBF shares performed in 2023?

3SBio's stock was trading at $0.80 at the start of the year. Since then, TRSBF stock has increased by 0.0% and is now trading at $0.80.
View the best growth stocks for 2023 here
.

Are investors shorting 3SBio?

3SBio saw a decline in short interest during the month of August. As of August 31st, there was short interest totaling 16,500 shares, a decline of 67.8% from the August 15th total of 51,200 shares. Based on an average daily trading volume, of 0 shares, the short-interest ratio is presently ∞ days.
View 3SBio's Short Interest
.

What is 3SBio's stock symbol?

3SBio trades on the OTCMKTS under the ticker symbol "TRSBF."

How do I buy shares of 3SBio?

Shares of TRSBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is 3SBio's stock price today?

One share of TRSBF stock can currently be purchased for approximately $0.80.

How many employees does 3SBio have?

The company employs 5,311 workers across the globe.

How can I contact 3SBio?

3SBio's mailing address is Shenyang Economy & Tech Development, Shenyang, Liaoning 110027. The official website for the company is www.3sbio.com. The company can be reached via phone at 86 24 2538 6000.

This page (OTCMKTS:TRSBF) was last updated on 9/22/2023 by MarketBeat.com Staff

My Account -